China Autoimmune Disease Diagnostics Market Size & Outlook, 2025-2029
China Autoimmune Disease Diagnostics Market Size
According to Straits Research analysis, the China Autoimmune Disease Diagnostics Market was valued at USD 381.29 Million in 2024 and is projected to reach USD 619.9 Million by 2029, expanding at a CAGR of 10.3% during the forecast period. Increased prevalence of autoimmune diseases including rheumatoid arthritis, lupus, and multiple sclerosis, are driving this significant growth. Key industry sectors, primarily pharma and biotechnology, are investing heavily to develop advanced diagnostic kits. An emerging trend is the application of AI, machine learning, and Big Data analytics to increase diagnostic precision and speed. Additionally, Green and sustainable production methods in the lab device manufacturing and the high export potential further boost market opportunities. In the future, China, being an epicenter of technology and innovation, is strategically positioning to dominate the autoimmune disease diagnostics market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Autoimmune Disease Diagnostics Market Highlights
- By 2024, Consumables & Assay Kits represented the largest share of the Product market size.
- Consumables & Assay Kits is expected to remain the key growth driver within Product, registering the fastest CAGR during the forecast period.
- As of 2024, China held 6.92% of the global autoimmune disease diagnostics market size.
- By 2029, United States is anticipated to capture the largest share of the global autoimmune disease diagnostics market.
- In Asia Pacific, China is expected to lead the regional autoimmune disease diagnostics market size by 2029.
- India will remain the fastest-growing market in Asia Pacific, reaching USD 58503 Million by 2029.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2029 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2029 |
| Market Size In 2024 | USD 381.29 Million |
| Market Size In 2029 | USD 619.9 Million |
| Largest segment | Consumables & Assay Kits |
| Fastest segment | Consumables & Assay Kits |
| Units | Revenue in USD Million |
| CAGR | 10.3% (2025-2029) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
China Autoimmune Disease Diagnostics Market Share By Product
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Product |
|
| Test type |
|
| Target disease |
|
| Systemic Autoimmune Disease, by Type |
|
| Localized Autoimmune Disease, by Type |
|
| End User |
|
China Autoimmune Disease Diagnostics Market By Product 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Autoimmune Disease Diagnostics Market By Test type 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Autoimmune Disease Diagnostics Market By Target disease 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Autoimmune Disease Diagnostics Market By Systemic Autoimmune Disease, by Type 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Autoimmune Disease Diagnostics Market By Localized Autoimmune Disease, by Type 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
China Autoimmune Disease Diagnostics Market By End User 2029
Source: Straits Research Analysis Company Publications, Primary Interviews.
